Estrogen Receptor Signaling in Breast Cancer
Estrogen receptor (ER) signaling is a critical regulator of cell proliferation, differentiation, and survival in breast cancer (BC) and other hormone-sensitive cancers. In this review, we explore the mechanism of ER-dependent downstream signaling in BC and the role of estrogens as growth factors necessary for cancer invasion and dissemination. The significance of the clinical implications of ER signaling in BC, including the potential of endocrine therapies that target estrogens' synthesis and ER-dependent signal transmission, such as aromatase inhibitors or selective estrogen receptor modulators, is discussed. As a consequence, the challenges associated with the resistance to these therapies resulting from acquired ER mutations and potential strategies to overcome them are the critical point for the new treatment strategies' development.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Cancers - 15(2023), 19 vom: 23. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Miziak, Paulina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Breast cancer |
|---|
| Anmerkungen: |
Date Revised 20.10.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/cancers15194689 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363283528 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363283528 | ||
| 003 | DE-627 | ||
| 005 | 20231226093018.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers15194689 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1210.xml |
| 035 | |a (DE-627)NLM363283528 | ||
| 035 | |a (NLM)37835383 | ||
| 035 | |a (PII)4689 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Miziak, Paulina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Estrogen Receptor Signaling in Breast Cancer |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.10.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Estrogen receptor (ER) signaling is a critical regulator of cell proliferation, differentiation, and survival in breast cancer (BC) and other hormone-sensitive cancers. In this review, we explore the mechanism of ER-dependent downstream signaling in BC and the role of estrogens as growth factors necessary for cancer invasion and dissemination. The significance of the clinical implications of ER signaling in BC, including the potential of endocrine therapies that target estrogens' synthesis and ER-dependent signal transmission, such as aromatase inhibitors or selective estrogen receptor modulators, is discussed. As a consequence, the challenges associated with the resistance to these therapies resulting from acquired ER mutations and potential strategies to overcome them are the critical point for the new treatment strategies' development | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a ER | |
| 650 | 4 | |a ER coregulators | |
| 650 | 4 | |a ER signaling | |
| 650 | 4 | |a breast cancer | |
| 650 | 4 | |a estrogen receptor | |
| 650 | 4 | |a post-translational modifications | |
| 650 | 4 | |a therapeutic targeting | |
| 700 | 1 | |a Baran, Marzena |e verfasserin |4 aut | |
| 700 | 1 | |a Błaszczak, Ewa |e verfasserin |4 aut | |
| 700 | 1 | |a Przybyszewska-Podstawka, Alicja |e verfasserin |4 aut | |
| 700 | 1 | |a Kałafut, Joanna |e verfasserin |4 aut | |
| 700 | 1 | |a Smok-Kalwat, Jolanta |e verfasserin |4 aut | |
| 700 | 1 | |a Dmoszyńska-Graniczka, Magdalena |e verfasserin |4 aut | |
| 700 | 1 | |a Kiełbus, Michał |e verfasserin |4 aut | |
| 700 | 1 | |a Stepulak, Andrzej |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d 2009 |g 15(2023), 19 vom: 23. Sept. |w (DE-627)NLM198667213 |x 2072-6694 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:19 |g day:23 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/cancers15194689 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 19 |b 23 |c 09 | ||